NEXGEL, Inc. (NXGLW) stock
NXGLWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 6/3072% below fair value
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $34.21MP/E –Yield –
Nexgel ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Nexgel's ebitda for the twelve months ending Jun 30, 2026 was -$4.25M. For fiscal 2025 it was -$2.90M. The highest annual figure on record is -$1.57M in fiscal 2018.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.90M | – |
| FY2024 | Dec 31, 2024 | -$3.12M | – |
| FY2023 | Dec 31, 2023 | -$3.25M | – |
| FY2022 | Dec 31, 2022 | -$3.24M | – |
| FY2021 | Dec 31, 2021 | -$2.46M | – |
| FY2020 | Dec 31, 2020 | -$2.21M | – |
| FY2019 | Dec 31, 2019 | -$1.86M | – |
| FY2018 | Dec 31, 2018 | -$1.57M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.68M | – |
| Q1 FY2026 | Mar 31, 2026 | -$859.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.10M | – |
| Q3 FY2025 | Sep 30, 2025 | -$612.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$525.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$663.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$733.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$604.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$972.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$809.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.10M | – |
| Q3 FY2023 | Sep 30, 2023 | -$577.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$725.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$852.00K | – |
| Q4 FY2022 | Dec 31, 2022 | -$753.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.01M | – |
| Q2 FY2022 | Jun 30, 2022 | -$689.00K | – |
| Q1 FY2022 | Mar 31, 2022 | -$784.00K | – |
| Q4 FY2021 | Dec 31, 2021 | -$980.00K | – |
| Q3 FY2021 | Sep 30, 2021 | -$460.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$524.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$493.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$696.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$486.00K | -692.7% |
| Q2 FY2020 | Jun 30, 2020 | -$529.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$499.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$299.00K | – |
| Q3 FY2019 | Sep 30, 2019 | $82.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.06M | – |
| Q1 FY2019 | Mar 31, 2019 | -$578.00K | – |